Back to Ask the Diabetes Team Ask the Diabetes Team

From Sibu, Malaysia:

Recently, the hospital that provides my Mixtard is running low, so the doctor would like to change me to either Actrapid [Regular] or Monotard [NPH}. I heard they would switch back once the stock is restored. Is that sensible? Is there any formula for the interchange?


I think that you would greatly benefit in terms of blood sugar stability and quite probably metabolic control as well if you stopped using Mixtard and began a regimen using Regular insulin at meals with Monotard at bedtime. In my experience, this approach is greatly superior when compared to the mixed insulins in achieving more stable blood sugar levels over the 24 hour period. If possible, try your best not to go back to Mixtard.


[Editor's comment: Mixtard is Novo Nordisk's brand name for their mixtures of fast-acting (soluble or Regular, brand name Actrapid or Novolin R) insulin, mixed with intermediate acting insulin (Isophane or NPH, brand name Insulatard and Protaphane) insulin. It is available in different ratios of R to N. Your doctor, diabetes nurse, or pharmacist can easily teach you how to mix the two products to get better control of your diabetes than by using premixes. Or, as Dr. Songini suggests, you can get even better control by splitting the shots into a basal/bolus insulin program. WWQ]

Original posting 4 Nov 2003
Posted to Insulin


  Back to Ask the Diabetes Team Return to the Top of This Page

Last Updated: Tuesday April 06, 2010 15:09:52
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.